Treatments for childhood anxiety disorders: Integrating physiological and psychosocial interventions

Expert Review of Neurotherapeutics

Volumn 11, Issue 8, 2011, Pages 1095-1097

  Rapee, Ronald M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

childhood anxiety; cognitive behavioral therapy; d cycloserine; gene environment interaction; pharmacotherapy

Indexed keywords

CYCLOSPORIN; PLACEBO; SERTRALINE;

ADULTHOOD; ANXIETY DISORDER; CHILD; CHILDHOOD ANXIETY DISORDER; CHILDHOOD DISEASE; COGNITIVE THERAPY; DEPRESSION; HUMAN; MONOTHERAPY; NONHUMAN; REVIEW; SUBSTANCE ABUSE; SUICIDE;

AFFECTIVE SYMPTOMS; ANXIETY DISORDERS; CHILD; CHILD BEHAVIOR DISORDERS; HUMANS; PSYCHOLOGY;

EID: 79961074072     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.11.85     Document Type: Review

References (15)

1. Slade T, Johnston A, Teesson M et al. The Mental Health of Australians 2: Report on the 2007 National Survey of Mental Health and Wellbeing. Department of Health and Ageing, Canberra, Australia (2009).
2. Rapee RM, Schniering CA, Hudson JL. Anxiety disorders during childhood and adolescence: origins and treatment. Ann. Rev. Clin. Psychol. 5, 311-341 (2009).
3. Last CG, Hansen C, Franco N. Anxious children in adulthood: a prospective study of adjustment. J. Am. Acad. Child Adolesc. Psychiatry 36(5), 645-652 (1997). (Pubitemid 27184072)
4. Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst. Rev. (3), CD005170 (2009).
5. James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst. Rev. 1, 1-25 (2006).
6. Otto MW, Mchugh K, Kantak KM. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: medication effects, glucocorticoids, and attenuated treatment outcomes. Clin. Psychol. Sci. Pract. 17, 91-103 (2010).
7. Walkup JT, Albano AM, Piacentini J et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N. Engl. J. Med. 359(26), 2753-2766 (2008).
8. Cahill L, Le Gorski K. Enhanced human memory consolidation with postlearning stress: interaction with the degree of arousal at encoding. Learning Mem. 10, 270-274 (2003). (Pubitemid 37013066)
9. NICE. NICE Guidance. NICE, London, UK (2010).
10. Walker DL, Davis M. The role of amygdala glutamate receptors in fear learning, potentiated startle, and extinction. Pharmacol. Biochem. Behav. 71(3), 379-392 (2002). (Pubitemid 34117707)
11. Norberg MM, Krystal JH, Tolin DF. A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biol. Psychiatry 63, 1118-1126 (2008).
12. Guastella AJ, Richardson R, Lovibond PF et al. A randomised controlled trial of d-cycloserine enhancement of exposure therapy for social phobia. Biol. Psychiatry 63, 544-549 (2008).
13. Storch EA, McKay D, Reid JM et al. d-cycloserine augmentation of cognitive-behavioral therapy: directions for pilot research in pediatric obsessive-compulsive disorder. Child Youth Care Forum 39(2), 101-112 (2010).
14. Byrne SP, Farrell LJ, Rapee RM. Using cognitive enhancers to improve the treatment of anxiety disorders in young people: examining the potential for d-cycloserine to augment exposure for child anxiety. Clin. Psychol. 15, 1-9 (2011).
15. Uher R. The implications of gene-environment interactions in depression: will cause inform cure? Mol. Psychiatry 13(12), 1070-1078 (2008).